In this study, we investigated the possible effect of liraglutide, a commonly used GLP-1 receptor agonist, on β-cell regeneration in T1D mice, and evaluated the combined effect of liraglutide with GCGR mAb. This evidence concerns the gene GLP1R and type 1 diabetes mellitus.